Systematic review: interferon-free regimens for patients with HCV-related Child C cirrhosis.
M GuarinoF MoriscoM R ValvanoAntonio Massimo IppolitoM LibrandiN AndriulliM GrecoA AmorusoA IacobellisG NiroN CaporasoA AndriulliPublished in: Alimentary pharmacology & therapeutics (2017)
The improvement in MELD scores strongly suggests HCV-positive patients with Child C cirrhosis should be treated with these agents.